Headline misstates source of economic woes in imaging
Your otherwise balanced article on the impact of the Deficit Reduction Act on medical imaging payments was marred by an unfortunate headline ("Trouble by the numbers: Imaging's reimbursement bubble bursts," August 2006, page 22). In fact, the imaging reimbursement environment bears no relationship to economic bubbles or the wasteful excesses that define them.
Medicare data show that many imaging procedures are paid below the true costs of providing the services, even now, before the DRA reductions are slated to be implemented. When the DRA cuts are factored in, reimbursement for some 80% of the affected imaging procedures will fall below the real-world costs that physicians face in providing the service, according to a recent preliminary analysis.
More broadly, medical imaging provides clear value to patients and to the healthcare system, whether that is measured in longer lives, improved efficiencies, shorter length-of-stay, earlier detection, or less invasive care. That is a sound, and welcome, economic reality.
-Andrew Whitman
National Electrical Manufacturers Association
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
